RLYB (Rallybio Corporation Common Stock) Stock Analysis - Politician Trades
Rallybio Corporation Common Stock (RLYB) is a publicly traded Healthcare sector company. As of May 21, 2026, RLYB trades at $14.43 with a market cap of $74.70M and a P/E ratio of -5.06. RLYB moved +2.18% today. Year to date, RLYB is +168.41%; over the trailing twelve months it is +427.04%. Its 52-week range spans $1.76 to $15.31. Rallies surfaces RLYB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded RLYB stock?
Rallies tracks politician and congressional stock disclosures for RLYB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
ADAR1 Capital Management, LLC bought 10.00K (~$139.82K) on May 19, 2026.
ADAR1 Capital Management, LLC bought 200 (~$2.76K) on May 19, 2026.
ADAR1 Capital Management, LLC bought 6.01K (~$83.98K) on May 18, 2026.
RLYB Analyst Consensus
RLYB analyst coverage data. Average price target: $0.00.
Common questions about RLYB
Which politicians traded RLYB stock?
Rallies tracks politician and congressional stock disclosures for RLYB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in RLYB?
Yes. Rallies tracks politician and congressional stock disclosures for RLYB, including reported purchases, sales, dates, owners, and trade amounts when available.
Is RLYB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RLYB. It does not provide personalized investment advice.